NewsBenzingaEos SENOLYTIX CEO To Deliver Industry Keynote On Advancing Mitochondrial-Targeted Geropeptide Medicine; Co. Expects To Close Pulmatrix Merger In Q4 Eos SENOLYTIX CEO To Deliver Industry Keynote On Advancing Mitochondrial-Targeted Geropeptide Medicine; Co. Expects To Close Pulmatrix Merger In Q4 Benzinga 2026.09.22 12:33 (GMT+0) Open on Benzinga Other news Tolan snags $30M for its AI companion that helps users navigate life Replika’s founder built the AI assistant she pitched at Disrupt 12 years ago Tenstorrent hits $6.2B valuation to scale open-weight AI chips Homebuilder Sentiment Hits 2012 Lows As Stocks Trade Like They Did During COVID-19 Pandemic Rain Says Western Union's Stablecard Is Live in 37 Markets FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated
